Literature DB >> 23449881

Probiotics and their Effects on Metabolic Diseases: An Update.

Juhi Aggarwal1, Gaurav Swami, Mayur Kumar.   

Abstract

Probiotics are lactic acid bacteria which are used extensively in therapeutic preparations and added to foods. There are many studies which have demonstrated the effects of probiotics on metabolic diseases. One study has shown the effect of fermented dairy products on the serum cholesterol, especially with selected strains of lactic acid bacteria. It has been found that a minute quantity of the dry culture of Lactobacillus fermentum KC4b, for example, can remove 14.8 mg of cholesterol from the culture medium. Lactobacilli also play an important role in deconjugating the bile salts in the intestine to form bile acids and thereby inhibiting the micelle formation. Probiotics reduce the lipid peroxidation and improve the lipid metabolism in vivo. The addition of probiotics to the diet for weeks improved the immune response without the release of inflammatory cytokines, thereby reducing the onset of systemic inflammatory induced diabetes. There are evidences that the differences in the composition of the gut microbiota may precede the development of obesity in children. This review has illustrated the potential of probiotics in mediating metabolic diseases via the positive modulation of several different physiological systems, apart from its conventional benefits for the gastrointestinal health.

Entities:  

Keywords:  Diabetes; Hyperlipidaemia; Lactobacillus; Metabolic diseases; Obesity; Probiotics

Year:  2013        PMID: 23449881      PMCID: PMC3576782          DOI: 10.7860/JCDR/2012/5004.2701

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  36 in total

Review 1.  Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism.

Authors:  M P St-Onge; E R Farnworth; P J Jones
Journal:  Am J Clin Nutr       Date:  2000-03       Impact factor: 7.045

Review 2.  Probiotics as functional food in the treatment of diarrhea.

Authors:  Fang Yan; D Brent Polk
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-11       Impact factor: 4.294

Review 3.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

4.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

5.  Effect of probiotic-fermented, genetically modified soy milk on hypercholesterolemia in hamsters.

Authors:  Tsung-Yu Tsai; Li-Ying Chen; Tzu-Ming Pan
Journal:  J Microbiol Immunol Infect       Date:  2012-06-29       Impact factor: 4.399

6.  Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice.

Authors:  T Matsuzaki; Y Nagata; S Kado; K Uchida; S Hashimoto; T Yokokura
Journal:  APMIS       Date:  1997-08       Impact factor: 3.205

7.  Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.

Authors:  Y Kadooka; M Sato; K Imaizumi; A Ogawa; K Ikuyama; Y Akai; M Okano; M Kagoshima; T Tsuchida
Journal:  Eur J Clin Nutr       Date:  2010-03-10       Impact factor: 4.016

8.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

9.  Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats.

Authors:  M Sipola; P Finckenberg; J Santisteban; R Korpela; H Vapaatalo; M L Nurminen
Journal:  J Physiol Pharmacol       Date:  2001-12       Impact factor: 3.011

10.  Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats.

Authors:  Hariom Yadav; Shalini Jain; P R Sinha
Journal:  Nutrition       Date:  2006-11-02       Impact factor: 4.008

View more
  14 in total

Review 1.  Physiology and its importance for reference intervals.

Authors:  Kenneth A Sikaris
Journal:  Clin Biochem Rev       Date:  2014-02

Review 2.  Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.

Authors:  Christy B Williamson; Cathleen M Burns; Crystal M Gossard; Jessica M Pizano; Keren E Dolan; Heather J Finley; Margaret G Gasta; Emily C Parker; Elizabeth A Lipski
Journal:  Integr Med (Encinitas)       Date:  2017-02

Review 3.  Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials.

Authors:  L Crovesy; M Ostrowski; D M T P Ferreira; E L Rosado; M Soares-Mota
Journal:  Int J Obes (Lond)       Date:  2017-07-10       Impact factor: 5.095

4.  Lactic acid bacterial infection, probiotics and gut microbiomes.

Authors:  John E Moore; Rosemary McKee; Patrick Wall; Colin E Goldsmith
Journal:  Ulster Med J       Date:  2014-01

5.  Impact of kefir derived Lactobacillus kefiri on the mucosal immune response and gut microbiota.

Authors:  P Carasi; S M Racedo; C Jacquot; D E Romanin; M A Serradell; M C Urdaci
Journal:  J Immunol Res       Date:  2015-02-24       Impact factor: 4.818

6.  The effects of probiotic supplementation on markers of blood lipids, and blood pressure in patients with prediabetes: a randomized clinical trial.

Authors:  Sepideh Mahboobi; Bijan Iraj; Zahra Maghsoudi; Awat Feizi; Reza Ghiasvand; Gholamreza Askari; Najmeh Maayeshi
Journal:  Int J Prev Med       Date:  2014-10

7.  Construction of a Recombinant Leuconostoc mesenteroides CJNU 0147 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Factor.

Authors:  Ji-Eun Eom; Gi-Seong Moon
Journal:  Korean J Food Sci Anim Resour       Date:  2015-12-31       Impact factor: 2.622

8.  Specific synbiotics in early life protect against diet-induced obesity in adult mice.

Authors:  Mona Mischke; Tulika Arora; Sebastian Tims; Eefje Engels; Nina Sommer; Kees van Limpt; Annemarie Baars; Raish Oozeer; Annemarie Oosting; Fredrik Bäckhed; Jan Knol
Journal:  Diabetes Obes Metab       Date:  2018-03-05       Impact factor: 6.577

Review 9.  The role of the gut microbiome in the pathogenesis and treatment of obesity.

Authors:  Francis Okeke; Bani Chander Roland; Gerard E Mullin
Journal:  Glob Adv Health Med       Date:  2014-05

10.  Effect of Cucurbita ficifolia and Probiotic Yogurt Consumption on Blood Glucose, Lipid Profile, and Inflammatory Marker in Type 2 Diabetes.

Authors:  Azade Bayat; Fatemeh Azizi-Soleiman; Motahar Heidari-Beni; Awat Feizi; Bijan Iraj; Reza Ghiasvand; Gholamreza Askari
Journal:  Int J Prev Med       Date:  2016-02-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.